Phase 1/2 Study of Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

Conditions:   Sarcoma, Ewing;   Rhabdomyosarcoma Interventions:   Drug: PEN-866;   Drug: Vincristine;   Drug: Temozolomide Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials